Veterinary Healthcare Market, By Product (Therapeutics and Diagnostics), By Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry, and Other Animals), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Dec 2022

Code : CMI5420

Pages :167

Formats :

Excel and PDF

Industry : Pharmaceutical

Leading Companies

Global Veterinary Healthcare Market: Key Developments

In May 2020, Krka tovarna zdravil d Novo mesto, a European pharmaceutical company, announced the launch of Prinocate (moxidectin and imidacloprid), prescription-only spot-on ectoparasiticide, for cats and dogs.

In January 2020, Whistle Labs launched Whistle Fit, which is specifically designed for pet health and fitness. It works as a preventative tool for the detection of itching and licking, and it has the capability of monitoring sleep in animals.

In August 2019, Boehringer Ingelheim launched a digital tool Dontstall.com, to help veterinarians diagnose equine protozoal myeloencephalitis (EPM), a protozoal disease that causes inflammation of the brain and/or spinal cord in horses.

Global Veterinary Healthcare Market: Key Companies Insights

The global veterinary healthcare market is highly competitive. This is attributed to the increase in awareness among people about veterinary healthcare, as a result, players in the market are focusing on launching novel products in the market.

Some of the key players in the global veterinary healthcare market are Zoetis Inc., Virbac SA, Vetoquinol SA, Phibro Animal Health, Merck & Co. Inc., IDEXX Laboratories, Ceva SantE Animale, BioMérieux SA, Elanco Animal Health Incorporated, and Boehringer Ingelheim International GmbH, among others.